The growing demand for more convenient and user-friendly diagnostic applications plays a major role in the rapid diagnostics test market. This includes one of the most popular applications – the rapid pregnancy test. Currently, the market offers primarily midstream urine tests.
Introducing SaliStick to the consumer answers a significant unmet need of the end user. SaliStick is a game changer, finally providing women with a test that meets their needs. With viral potential and smart marketing, Salistick can gain significant market share.
We are currently seeking strategic partners which have the vision and ability to take part in the distribution of SaliStick.
If you wish to join us, contact us below:
Guy Krief, PhD
Deputy CEO at Salignostics
